We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19.
- Authors
Khatib, Mohamad Y.; Shaik, Karimulla S.; Ahmed, Amna A.; Alwraidat, Mohammad A.; Mohamed, Ahmed S.; Abou Kamar, Mohamad R.; Sharaf Eldean, Mouhammad Z.; Aldaraiseh, Bashar K.; Nashwan, Abdulqadir J.
- Abstract
The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment will prevent life‐threatening bleeding and mortality.
- Subjects
COVID-19; COLITIS; CYTOMEGALOVIRUSES; GASTROINTESTINAL hemorrhage; CYTOMEGALOVIRUS diseases
- Publication
Clinical Case Reports, 2021, Vol 9, Issue 1, p148
- ISSN
2050-0904
- Publication type
Article
- DOI
10.1002/ccr3.3487